Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
Stevanato (STVN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
United Therapeutics (UTHR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
United Therapeutics (UTHR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C., April 24, 2024--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced the world’s first successful transplant of a UThymoKidney™, which the company produced, into a living person on April 12, 2024. This transplant represents several historic firsts for transplantation:
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C., April 24, 2024--United Therapeutics Corporation (Nasdaq: UTHR), announced today that it will report its first quarter 2024 financial results before the market opens on Wednesday, May 1, 2024. A press release detailing the quarterly results will be issued that day at approximately 6:30 a.m. Eastern Time.
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C., April 16, 2024--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that recent research across its commercial and development portfolio will be presented at the American Thoracic Society (ATS) International Conference in San Diego on May 17-22, 2024. At ATS, United Therapeutics will host an educational industry theater on implementing treprostinil induction strategies in pulmonary hypertension, and the
This article examines the first index rebalance and reconstitution of 2024 for the ROBO Global Healthcare Technology and Innovation Index, which underlies the $63 million ROBO Global Healthcare Technology and Innovation ETF (HTEC). Index movements are due to scoring changes from a combination of sector trends, individual companies’ financial health, quantitative analysis, and the insights [...]
Martine Rothblatt, Chairperson & Chief Executive Officer of United Therapeutics Corp (NASDAQ:UTHR), sold 30,000 shares of the company on April 4, 2024, according to a recent SEC filing.
Paul Mahon, EVP & GENERAL COUNSEL of United Therapeutics Corp (NASDAQ:UTHR), sold 6,000 shares of the company on April 4, 2024, according to a recent SEC filing.
The healthcare sector is a constant source of innovation and growth. Yet, even amidst the spotlight on industry giants, a realm of underappreciated gems still exists. The top underappreciated healthcare stocks to buy offer a unique opportunity for savvy investors to capitalize on burgeoning trends and new drug discoveries. While some players may operate in niche segments, their potential for substantial returns makes them compelling growth prospects. As investors continue to seek opportunities f